GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 26 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 6.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 1,600 | +128.6% | 0.00% | – |
| Q1 2021 | $0 | – | 700 | -12.5% | 0.00% | – |
| Q4 2020 | $0 | – | 800 | +33.3% | 0.00% | – |
| Q3 2020 | $0 | – | 600 | -14.3% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 700 | -87.7% | 0.00% | – |
| Q1 2020 | $1,000 | -66.7% | 5,700 | +42.5% | 0.00% | – |
| Q4 2019 | $3,000 | – | 4,000 | +3900.0% | 0.00% | – |
| Q3 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 100 | -75.0% | 0.00% | – |
| Q1 2019 | $3,000 | -96.2% | 400 | -96.6% | 0.00% | -100.0% |
| Q4 2018 | $80,000 | -7.0% | 11,700 | +4.5% | 0.01% | +16.7% |
| Q3 2018 | $86,000 | +8500.0% | 11,200 | +11100.0% | 0.01% | – |
| Q2 2018 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 202,100 | $2,318,000 | 1.99% |
| Gerry Farber, LLC | 52,000 | $596,000 | 1.03% |
| Granite Point Capital Management, L.P. | 115,000 | $1,319,000 | 0.94% |
| 683 Capital Management, LLC | 158,735 | $1,821,000 | 0.71% |
| SPHERA FUNDS MANAGEMENT LTD. | 170,000 | $1,950,000 | 0.44% |
| Knoll Capital Management, LLC | 65,000 | $746,000 | 0.39% |
| Healthcare Value Capital, LLC | 50,000 | $574,000 | 0.38% |
| Park West Asset Management LLC | 200,000 | $2,294,000 | 0.26% |
| Perceptive Advisors | 75,000 | $860,000 | 0.09% |
| HIGHLAND CAPITAL MANAGEMENT LP | 126,956 | $1,456,000 | 0.06% |